Stopping Neurogenesis in Transgenic Mice and Rat Models that Express the HSV-thymidine kinase Gene in Neuronal Precursor Cells

Description:
This invention relates to novel mouse and rat models that permit the temporal death of neuronal precursor cells at any time point. Other existing methods of decreasing neurogenesis are relatively non-specific (e.g., injecting glucocorticoids) or require expensive equipment (e.g., focal x-irradiation)
These mice and rats are being used to inhibit adult neurogenesis in order to study the normal function of adult neurogenesis and to model disease states thought to feature decreased neurogenesis, such as chronic stress, anxiety, and depression.
The murine models have been engineered to express a herpes simplex virus gene called HSV-TK in neuronal precursor cells (through the use of a GFAP promoter). Cells that express HSV-TK undergo programmed death when exposed to a molecule called ganciclovir. The combination of these elements permits stopping neurogenesis at any time point in development by selectively providing ganciclovir to mice or rats expressing HSV-TK in neuronal precursor cells.
Patent Information:
For Information, Contact:
Jennifer Wong
Technology Development Coordinator
NIH Technology Transfer
301-828-3707
jennifer.wong2@nih.gov
Inventors:
James Pickel
Heather Cameron
Keywords:
Driving
Expression
GFAP
HSV
Kinase
Listed LPM Maddox as of 4/15/2015
Mice
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
PROMOTER
RATS
Thymidine
TRANSGENIC
VEXXXX
WIXXXX
XEXXXX
© 2024. All Rights Reserved. Powered by Inteum